Skip to content

Specialized Palliative Telemedicine for Patients with Advanced Cancer

The Effect of Specialized Palliative Telemedicine for Patients with Advanced Cancer At Home

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05231070
Acronym
TeleSPC
Enrollment
60
Registered
2022-02-09
Start date
2022-12-01
Completion date
2024-12-31
Last updated
2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Cancer, telemedicine, dyadic coping, palliative care

Brief summary

Specialized palliative care (SPC) plays an important role in providing patient-centered care and support to informal caregiver, besides establishing/intensifying/coordinating collaboration with primary and secondary health care sectors (hospital nurse/district nurse and general practitioner/oncologist) to improve care and support for patients and burdened informal caregiver. This study proposes to develop a SPC intervention enriched with a dyadic psychological intervention for patients with advanced cancer and their informal caregiver delivered by telemedicine at home (TeleSPC). It is our hypothesis that the intervention can enhance patient-centered care at home, support their informal caregiver, and improve relations/integration between the SPC teams, oncologic teams, the general practitioners and district nurses.

Detailed description

This is a pilot randomized controlled trial in an open-label fashion, which proposes to develop a SPC intervention enriched with a dyadic psychological intervention (needs-based therapeutic framework based on existential-phenomenological therapy) for patients with advanced cancer and their informal caregiver delivered by telemedicine (video consultation) at home. The primary aim is to investigate the intervention effects on the patients' health-related quality of life (HRQoL). The secondary aims will be to analyze the intervention effects on number of hospitalizations, days spent at home, hospital admissions, survival, dyadic coping between patients and informal caregiver, staff satisfaction with the intervention and caregiver burden in patients' informal caregiver.

Interventions

OTHERTeleSPC

Multidisciplinary video consultations with the SPC team. The team is multiprofessional and composed by physician, nurse, psychologist, social worker, physiotherapist and a chaplain, which is in line with the staffing of most SPC teams in Denmark and abroad. Video consultations will follow the same approach already used in physical consultations at the Section of Palliative Medicine, considering patients' changing needs and providing differentiated treatment and support, with the addition of a psychological intervention for dyadic coping between patient and closest informal caregiver

Sponsors

Danish Cancer Society
CollaboratorOTHER
Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Randomized controlled trial, in which patients will be randomly assigned either to one of the two arms (1:1): intervention (TeleSPC) or control group (standard care). Assessment will occur at inclusion (baseline) and after 2 weeks, 4 weeks, 8 weeks, and 6 months. sample will be composed by 87 patients in each group and their informal caregiver (1 informal caregiver per patient) .

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Patient inclusion criteria: * adults (at least 18 years old) * solid organ cancer * no longer receives curativ treatment * provide written informed consent * are able to speak and understand Danish Language * are cognitively able to participate in the study * have at least one symptom or problem with score ≥ 3 at the EORTC QLQ-C30 Patient

Exclusion criteria

* primary brain cancer or central nervous system metastases * a prognosis of less than six months * incapable of cooperating in the trial * already receive SPC Informal caregiver inclusion criteria: * adults (at least 18 years old) * indicated by the patient as the closest informal caregiver * able to speak and understand danish langues * provide written informed consent Informal caregiver

Design outcomes

Primary

MeasureTime frameDescription
Change from baseline patient's health-related quality of life at 2 weeks, 4 weeks, 8 weeks, and 6 monthsBaseline, 2 weeks, 4 weeks, 8 weeks, and 6 monthsThe European Organisation for Research and Treatment of Cancer Quality of life Questionnaire - Core 30 (EORTC QLQ-C30) to assess several physical and psychosocial aspects of the patient's health-related quality of life. Scores range from 0 to 100; high values in the functioning and quality of life scales and low values in the symptoms scales indicate better outcomes.

Secondary

MeasureTime frameDescription
Change from baseline patients and informal caregiver dyadic coping at 4 weeks, 8 weeks, and 6 monthsBaseline, 4 weeks, 8 weeks, and 6 monthsDyadic Coping inventory to assess how patients and informal caregiver manage stress together concerning decision making and giving support to each other. Four subscales were selected to evaluate dyadic coping (dyad patient and relative/caregiver) regarding stress communicated by oneself (max. score 20), stress communication of the partner (max. score 20), common dyadic coping (max. score 25), and evaluation of dyadic coping (max score 10). Higher scores denote greater levels of the constructs measured by each subscale.
Change from baseline caregiver burden at 4 weeks, 8 weeks, and 6 monthsBaseline, 4 weeks, 8 weeks, and 6 monthsZarit Burden Interview to measure subjective burden among caregivers. Sum of scores ranges from 0 to 88. A score of 17 or more is considered high burden.
Change from baseline informal caregiver health related quality of life at 4 weeks, 8 weeks, and 6 monthsBaseline, 4 weeks, 8 weeks, and 6 monthsRAND 36-Item Short Form Health Survey version 1.0. Scores range from 0 to 100; a higher score indicates a better result.
Healthcare professionals' satisfaction with intervention at 6 months6 monthsInterview with healthcare providers
Change from baseline patients' sleep at 2 weeks, 4 weeks, 8 weeks, and 6 monthsBaseline, 2 weeks, 4 weeks, 8 weeks, and 6 monthsPittsburg Sleep Quality Index to determining the quality and patterns of sleep. Global score ranges from 0 to 21; 0 indicates no difficult and 21 indicates severe difficlties in all areas.
Change from baseline patients' use of health care system at 6 monthsBaseline and 6 monthsClinical information collected from patients' records regarding number of hospitalizations, days spent in hospital, and date of death
Change from baseline patient's depression at 2 weeks, 4 weeks, 8 weeks, and 6 monthsBaseline, 2 weeks, 4 weeks, 8 weeks, and 6 monthsHospital anxiety and depression scale. Scores range from 0 to 21; 0-7 represent non-cases, 8-10 represent doubtful cases, and 11-21 represent definite cases.
Patients and informal caregivers' satisfaction with intervention at 6 months6 monthsPatients and informal caregivers will be requested to rate their satisfaction (scale 1-5), and will have the possibility to write any comment
Change from baseline informal caregivers' anxiety at 4 weeks, 8 weeks, and 6 monthsBaseline, 4 weeks, 8 weeks, and 6 monthsPatient Health Questionnaires' scales (GAD-7). Seven items, each of which is scored 0 to 3, providing a 0 to 21 severity score.
Change from baseline informal caregivers' depression at 4 weeks, 8 weeks, and 6 monthsBaseline, 4 weeks, 8 weeks, and 6 monthsPatient Health Questionnaires' scales (PHQ). Nine items, each of which is scored 0 to 3, providing a 0 to 27 severity score.
Change from baseline patients' anxiety at 2 weeks, 4 weeks, 8 weeks, and 6 monthsBaseline, 2 weeks, 4 weeks, 8 weeks, and 6 monthsHospital anxiety and depression scale. Scores range from 0 to 21; 0-7 represent non-cases, 8-10 represent doubtful cases, and 11-21 represent definite cases.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026